Statewide Medicaid Expansion and Survival in Resectable Non–Small Cell Lung Cancer
In this cohort study of patients with stage I to IIIA NSCLC, Medicaid expansion was associated with lower mortality at 2 and 4 years. These findings suggest that expanded insurance coverage may have enhanced access to effective cancer care and improved population-level outcomes.
Authors
- Paul C. Lee (ORCID: https://orcid.org/0000-0002-7380-2181)
- David Zeltsman
- Shahidul Islam (ORCID: https://orcid.org/0000-0002-9385-101X)
- Shangyi Liu
- Lawrence Glassman
- Rohin Gawdi (ORCID: https://orcid.org/0000-0002-2088-2253)
- Chulin Sha (ORCID: https://orcid.org/0000-0001-8725-8642)
- Kevin Hyman
- Julissa Jurado
Institutions
- Northwell Health (US)
- Long Island Jewish Medical Center (US)
- Massachusetts General Hospital (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.45996
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00